Myocardial Protection and Current Cancer Therapy - Semantic Scholar
Dual low dose combination: CCB+TD or CCB+ACEI/ARB, or ACEI/ARB+TD ... CTR-CVT risk may vary according to cancer type and stage, anticancer drugs, doses ...
Potential Role of Global Longitudinal Strain in Cardiac and ...2022 ESC Guidelines on cardio-oncology developed in collaboration with the European. Hematology Association (EHA), the European Society for Therapeutic ... kenya-national-guidelines-for-cardiovascular-diseases ...Aims. Cancer treatment?related cardiovascular toxicity (CTR-CVT) is a growing concern in patients undergoing anticancer ther-. University of Groningen 2022 ESC Guidelines on cardio-oncology ...Cancer Therapy-related. Cardiovascular Toxicity (CTR-CVT) is now the leading cause of morbidity and mortality in cancer survivors [6]. It is for ...
Autres Cours:
